doi:10.1016/S0065-2164(08)70476-3
Injections : 1,000 mcg IM weekly or monthly depending on need [*]
most research based on animal and preclinical studies TB500 displays a favorable safety profile in preclinical data but lacks long-term human outcome data. Goldstein et al., Annals of the New York Academy of Sciences Side Effect Comparison Summary Conclusion: Which Peptide Is Right for You
Therapies that do not cause any change in the host genome include the use of non-coding RNA (nc-RNA) antisense oligonucleotides (ASO), RNA editing, and gene delivery
Ideal candidates are those who are willing to commit to a healthy lifestyle, exercise, and diet
All experiments received specific approval from the local Ethics Committee at the School of Medicine (the University of Zagreb, Zagreb, Croatia)